Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil. (2017)
Attributed to:
Newton001: Brazil-UK collaboration in Health Technology Assessment of diagnostic strategies for infectious diseases
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12876-017-0676-8
PubMed Identifier: 29169329
Publication URI: http://europepmc.org/abstract/MED/29169329
Type: Journal Article/Review
Volume: 17
Parent Publication: BMC gastroenterology
Issue: 1
ISSN: 1471-230X